» Articles » PMID: 39114551

Long-Term Effects of the Multicomponent Program BrainProtect on Cognitive Function: One-Year Follow-Up in Healthy Adults

Overview
Publisher IOS Press
Date 2024 Aug 8
PMID 39114551
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Age-related neuronal changes impact cognitive integrity, which is a major contributor to health and quality of life. The best strategy to prevent cognitive decline and Alzheimer's disease is still debated.

Objective: To investigate the long-term effects of the eight-week multicomponent training program BrainProtect on cognitive abilities compared to general health counseling (GHC) in cognitively healthy adults in Germany.

Methods: Healthy adults (age ≥50 years) previously randomized to either GHC ( = 72) or BrainProtect (intervention group, IG,  = 60) for eight-weeks (once weekly, 90 minutes, group-based) underwent a comprehensive neuropsychological test battery and health-related quality of life (HRQoL) evaluation 3- and 12-months after intervention end.

Results: Dropout rates were  = 8 after 3 months and  = 19 after 12 months. No significant long-term effect of BrainProtect was observed for the primary endpoint Consortium to Establish a Registry for Alzheimer's Disease (CERAD-Plus) total score. Logical reasoning was significantly improved ( = 0.024) 12 months after completion of the training program in IG participants compared to the GHC group independent of sex, age, education, diet, and physical activity. In IG participants, thinking flexibility ( = 0.019) and confrontational naming ( = 0.010) were improved 3 months after completing the intervention compared to the GHC group, however, after conservative Bonferroni adjustment, significance was lost.

Conclusions: BrainProtect independently improved logical reasoning compared to GHC up to 12 months after cognitive training's end in healthy adults. To uncover the long-term clinical significance of multicomponent cognitive training in healthy adults, studies with larger sample size and frequent follow up visits are necessary.

References
1.
Stern Y . Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012; 11(11):1006-12. PMC: 3507991. DOI: 10.1016/S1474-4422(12)70191-6. View

2.
Cristofori I, Cohen-Zimerman S, Grafman J . Executive functions. Handb Clin Neurol. 2019; 163:197-219. DOI: 10.1016/B978-0-12-804281-6.00011-2. View

3.
Kivipelto M, Mangialasche F, Snyder H, Allegri R, Andrieu S, Arai H . World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia. Alzheimers Dement. 2020; 16(7):1078-1094. PMC: 9527644. DOI: 10.1002/alz.12123. View

4.
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011; 20(10):1727-36. PMC: 3220807. DOI: 10.1007/s11136-011-9903-x. View

5.
Rosenberg A, Mangialasche F, Ngandu T, Solomon A, Kivipelto M . Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS. J Prev Alzheimers Dis. 2020; 7(1):29-36. PMC: 7222931. DOI: 10.14283/jpad.2019.41. View